APTATARGETS
AptaTargets is a biopharmaceutical company focused in developing therapeutic applications based in aptamer technology. AptaTargets drug candidates start at preclinical stages and aims to reach phase 2 of clinical trials
APTATARGETS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2015-01-01
Address:
Madrid, Madrid, Spain
Country:
Spain
Website Url:
http://www.aptatargets.com
Total Employee:
1+
Status:
Active
Contact:
+34910075622
Email Addresses:
[email protected]
Total Funding:
7.7 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Google Maps Global Site Tag
Similar Organizations
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Current Advisors List
Current Employees Featured
Founder
Investors List
EIC Accelerator
EIC Accelerator investment in Grant - AptaTargets
Inveready
Inveready investment in Series B - AptaTargets
Centre for the Development of Industrial Technology (CDTI)
Centre for the Development of Industrial Technology (CDTI) investment in Series B - AptaTargets
Inveready
Inveready investment in Venture Round - AptaTargets
Criteria Venture Tech
Criteria Venture Tech investment in Venture Round - AptaTargets
Official Site Inspections
http://www.aptatargets.com Semrush global rank: 9.59 M Semrush visits lastest month: 348
- Host name: 172.67.181.96
- IP address: 172.67.181.96
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AptaTargets"
AptaTargets - Crunchbase Company Profile & Funding
Organization. AptaTargets . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ...See details»
AptaTargets
AptaTargets is a biopharmaceutical company specializing in therapeutic applications using aptamer technology.See details»
aptaTargets - LinkedIn
AptaTargets is a clinical stage biopharmaceutical company focused in developing therapeutic applications based on aptamer technology. Our candidates are neuroprotectants and immunomodulators being ...See details»
AptaTargets Company Profile - Office Locations, Competitors
AptaTargets has 5 employees at their 1 location and $2.98 m in total funding,. See insights on AptaTargets including office locations, competitors, revenue, financials, executives, …See details»
AptaTargets - The Org
AptaTargets is a biopharmaceutical company focused in developing therapeutic. Industries. Biotechnology, Life Sciences + 1See details»
AptaTargets - VentureRadar
AptaTargets is a biopharmaceutical company focused in developing therapeutic applications based on aptamer technology. AptaTargets drug candidates start at preclinical stages and …See details»
AptaTargets 2025 Company Profile: Valuation, Funding
AptaTargets was founded in 2014. Where is AptaTargets headquartered? AptaTargets is headquartered in Madrid, Spain. What is the size of AptaTargets? AptaTargets has 10 total …See details»
About us - aptaTargets, currently developing ApTOLL
Focused on therapeutic aptamers, aptaTargets is currently developing ApTOLL, an immune modulator which represents a novel approach to treat ischemic stroke in the acute phase by …See details»
AptaTargets - Products, Competitors, Financials, Employees ...
AptaTargets was founded in 2014. Where is AptaTargets's headquarters? AptaTargets's headquarters is located at Avenida Cardenal Herrera Oria, 298, Madrid. What is AptaTargets's …See details»
aptaTargets – Oligofastx
AptaTargets is a clinical-stage biopharmaceutical company specializing in the development of innovative therapies based on aptamer technology. The company’s main drug is ApTOLL, an aptamer (single-stranded DNA molecule) …See details»
Our team - aptaTargets, clinical-stage company
David, an aptamer technology entrepreneur, co-founded aptaTargets in 2014 and has led the company to bring ApTOLL to the clinic. Previously, he was the co-founder and CEO of Aptus …See details»
aptaTargets - app.biopharmiq.com
About: aptaTargets is a clinical stage biopharmaceutical company focused in developing therapeutic applications based on aptamer technology. Our candidates are neuroprotectants …See details»
AptaTargets - Funding, Financials, Valuation & Investors
AptaTargets is a biopharmaceutical company focused in developing therapeutic. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. ... How much funding has …See details»
aptaTargets Overview | SignalHire Company Profile
To connect with aptaTargets employee register on SignalHire. Organization Website: aptatargets.com : Social Links: Contact Email: [email protected]: Phone Number: 34-910 …See details»
Our history - aptaTargets, a clinical-stage company
Founded in 2014, aptaTargets was spun-out of Aptus Biotech, an aptamer technology platform. aptaTargets started a drug development program collaborating with the Complutense …See details»
CEO and Co-Founder of aptaTargets - Genesis Biomed
Oct 9, 2024 Previously, he was co-founder and CEO of Aptus Biotech, an aptamer platform focused on therapeutic and diagnostic applications from which aptaTargets emerged as a spin …See details»
aptaTargets News and Updates
AptaTargets has completed the enrollment of the First-in-human ApTOLL-FIH-01 trial, a dose ascending, randomized, placebo-controlled clinical trial to assess tolerability and …See details»
AptaTargets - Contacts, Employees, Board Members, Advisors
Organization. AptaTargets . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Contacts 1. About. AptaTargets has 3 current employee profiles, including …See details»
‘JAMA Neurology’ publishes results from Phase 1b/2a trial of …
2 days ago aptaTargets has announced an agreement with Merck, signed in October 2024, for the clinical development and commercialization of ApTOLL, a Toll-like receptor 4 (TLR4) …See details»
Target Corporation Announces Multi-Year Enterprise Acceleration …
3 days ago MINNEAPOLIS, May 21, 2025 /PRNewswire/ -- Target Corporation (NYSE: TGT) announced today it has established a multi-year Enterprise Acceleration Office to drive even …See details»